Clinical Trial Update: Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and efficacy of K-877 in adults with fasting high triglycerides and normal renal function has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• K-877 (pemafibrate)

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Severe Hypertriglyceridemia | Phase 3 | Status: COMPLETED | Results posted: 2022-11-30